ArticleClinical ophthalmology (Auckland, N.Z.)2025

Treat and Extend Regimen of Aflibercept in the Treatment of Type 1 Choroidal Neovascularization Secondary to Chronic Central Serous Chorioretinopathy: Three-year Follow-Up.

Taras B Kustryn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.